IP Library › Assignment 061315/0428
Patent Assignment
Reel/Frame 061315/0428

Merger

Recorded: 2022-08-25 Pages: 22
Assignor
2831094 ONTARIO INC.
Executed: 2021-06-02
Assignee
ANTIBE AMALCO INC.
15 PRINCE ARTHUR AVENUE, TORONTO, M5R 1B2, CANADA
Covered Properties (2)
Hydrogen Sulfide Derivatives of Non-Steroidal Anti-Inflammatory Drugs
Patent: 7,741,359 →
Application: 11/779,849 →
Publication: US 2008/0004245
Hydrogen Sulfide Derivatives of Non-Steroidal Anti-Inflammatory Drugs
Patent: 8,541,398 →
Application: 12/704,412 →
Publication: US 2010/0210607
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 11, 2007
From: WALLACE, JOHN L.; CIRINO, GIUSEPPE; SANTAGADA, VINCENZO; CALIENDO, GIUSEPPE
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 019811/0169 →
Assignment of Assignor's Interest Feb 12, 2010
From: WALLACE, JOHN L.; CIRINO, GIUSEPPE; SANTAGADA, VINCENZO; CALIENDO, GIUSEPPE
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 023930/0351 →
Change of Name Nov 5, 2013
From: ANTIBE THERAPEUTICS INC.
To: ANTIBE HOLDINGS INC.
Reel/Frame 031580/0142 →
Merger Aug 25, 2022
From: ANTIBE AMALCO INC.; ANTIBE THERAPEUTICS INC.
To: ANTIBE THERAPEUTICS INC.
Reel/Frame 061315/0501 →
Corrective Assignment to Correct the Add the Second Assignor Previously Recorded at Reel: 061315 Frame: 0428. Assignor(S) Hereby Confirms the Assignment. Nov 29, 2022
From: 2831094 ONTARIO INC.; ANTIBE HOLDINGS INC.
To: ANTIBE AMALCO INC.
Reel/Frame 062015/0794 →